TG THERAPEUTICS INC. - COMMON STOCK
16.92
09-May-24 15:59:59
15 minutes delayed
Stocks
-0.20
-1.17%
Today's range
16.83 - 17.34
ISIN
N/A
Source
NASDAQ
-
26 Jan 2023 07:00:01 By Nasdaq GlobeNewswire
-
TG Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
06 Jan 2023 07:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy)
28 Dec 2022 13:48:07 By Nasdaq GlobeNewswire
-
TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
10 Nov 2022 07:30:01 By Nasdaq GlobeNewswire
-
TG Therapeutics to Host Conference Call on Third Quarter 2022 Financial Results and Business Update
08 Nov 2022 07:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
09 Sep 2022 07:30:00 By Nasdaq GlobeNewswire
-
25 Aug 2022 07:30:47 By Nasdaq GlobeNewswire
-
TG Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
08 Aug 2022 07:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics to Host Conference Call on Second Quarter 2022 Financial Results and Business Update
05 Aug 2022 07:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics Announces FDA Extension of BLA PDUFA Date for Ublituximab to Treat Patients with RMS
31 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
20 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
26 Apr 2022 07:30:00 By Nasdaq GlobeNewswire
-
15 Apr 2022 08:30:00 By Nasdaq GlobeNewswire
-
06 Apr 2022 07:30:00 By Nasdaq GlobeNewswire